Why I’m Looking to Load Up on Energy and AI

by Graham Lindman | Apr 30, 2025

I get asked a lot if I’m still bullish after everything that’s happened this year?

Short answer?

Yes!

Long answer?

Very much yes!

Let’s start with something I showed this week: the breadth thrust signal. It’s a rare indicator, and every time it’s fired in the past 80 years, the market’s gone higher over the next 12 months.

I’m talking about a 100% hit rate. That doesn’t mean we won’t get some volatility in the meantime, but for long-term investors, this is the kind of green light we wait for.

Now, layer that with what we’re seeing in energy demand — especially around AI. Look at the data: Energy needs are about to go vertical. Why?

Because powering AI takes a lot more juice than people think. And as I showed on Tuesday, the U.S. has a lot of catching up to do if we want to stay competitive globally.

That’s why I’m so bullish on names like GE Vernova (GEV) and Oklo (OKLO).

GEV is a smart long-term bet, and OKLO (more speculative) has already run from $8 to $60 once. It’s pulled back — but I think it can do it again. These are the types of plays that could lead the charge in the AI-energy race.

Last thing I’ll say…

Don’t sleep on stocks that beat earnings and still drop. That’s where the opportunity is hiding. A great example? Intuitive Surgical (ISRG). It dropped hard on earnings, even though results were solid. I called it out right away, and now it’s bounced nearly 20%.

Bottom line — I’m not here to chase. I’m here to stack smart trades and build long-term winners.

The data’s lining up. The setups are forming.

You just have to stay ready.

AbbVie (ABBV) In Bullish Mode

While most of the market has been a hot mess this year, AbbVie (ABBV) has outperformed.

ABBV has been quietly crushing it lately — and for good reason.

After some early worries about what would happen once Humira lost exclusivity, the company has done a great job showing investors it has strong backup plans.

Drugs like Skyrizi and Rinvoq are gaining steam, and their most recent earnings report gave everyone a boost of confidence. Add in a rock-solid dividend and the fact that health care stocks tend to hold up well in choppy markets, and it’s no surprise ABBV has been outpacing the S&P 500 lately.

At the same time, our Newton Indicator is in bullish mode. As the stock has started to move up, it’s gone from red to yellow to green.

This indicates it has excellent momentum and could be ready to make a run.

Kimco Realty Corp. (KIM) Looking Bearish

On the flip side, Kimco Realty Corp. (KIM) is looking like it’s ready for a drop.

KIM just can’t catch a break lately.

The stock’s been dragging and a lot of it comes down to two things: interest rates and retail. Since KIM is a retail-focused REIT, it’s super sensitive to borrowing costs…

And with rates staying high, that’s been a headwind. Add in some shaky retail earnings and concerns about consumer spending, and suddenly investors aren’t too excited about the outlook. All that pressure has weighed on KIM, leading to some serious underperformance.

And the Newton Indicator shows that momentum has gone from red to yellow… and back to red. It looks like it could be ready to roll over, especially if its upcoming earnings report disappoints.